Advanced Therapy Medicinal Products Market Growth Outlook Indicating Expansion To $124.43 Billion By 2030
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Advanced Therapy Medicinal Products Market Between 2026 And 2030?
The advanced therapy medicinal products market size has recently seen substantial growth. This market is projected to expand from $51.34 billion in 2025 to $61.41 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.6%. Historically, this market’s expansion was influenced by factors such as the restricted availability of advanced therapy products, a reliance on traditional biologics, developing regulatory frameworks, the high cost of gene and cell therapies, and limited distribution channels.
The advanced therapy medicinal products market is projected to witness significant growth in the upcoming years. Its valuation is anticipated to climb to $124.43 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.3%. This projected expansion is driven by various factors, including technological breakthroughs in gene editing and stem cell therapies, escalating investment in personalized medicine, the increasing occurrence of rare and chronic ailments, the widening reach of hospital pharmacy and specialty clinic networks, and the adoption of AI-powered manufacturing and automation systems. Key trends for the forecast period encompass the increasing acceptance of autologous and allogeneic treatments, the advancement of gene editing and viral vector technologies, a sharper focus on rare disease therapies, the integration of automation in therapy production, and stronger collaborations between hospitals and specialty clinics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp
What Important Drivers Are Powering The Advanced Therapy Medicinal Products Market Growth?
An increasing call for personalized medicine is projected to propel the expansion of the advanced therapy medicinal products market in the future. Personalized medicine defines a medical strategy that tailors treatment and prevention plans based on an individual’s unique genetic composition, lifestyle, and environment. The escalating requirement for personalized medicine primarily arises from the rising occurrence of chronic conditions, as it enables customized treatments that improve patient outcomes and lessen adverse effects for individuals. Advanced therapy medicinal products support personalized medicine by offering bespoke treatments like gene, cell, and tissue-engineered therapies, which target the distinct genetic and biological profiles of individual patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. The recently sanctioned personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine acts as a driver for the growth of the advanced therapy medicinal products market.
Which Segment Groups Define The Advanced Therapy Medicinal Products Market Landscape?
The advanced therapy medicinal products market covered in this report is segmented –
1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products
2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes
3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy
2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes
3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies
What Trends Are Influencing The Advanced Therapy Medicinal Products Market Outlook?
Leading entities within the advanced therapy medicinal products (ATMP) market are prioritizing the creation of novel therapies, including gene editing cell therapies, aimed at delivering precise and potentially healing interventions for ailments such as ß thalassemia and sickle cell disease. These gene editing cell therapies entail gathering a patient’s hematopoietic stem cells and accurately altering their genome outside the body, frequently employing CRISPR Cas9 to rectify detrimental mutations or stimulate advantageous genetic routes, thereby presenting a customized option to conventional allogeneic bone marrow transplantation, which necessitates donor compatibility and entails hazards like graft versus host disease. An illustrative example is from January 2024, when Vertex Pharmaceuticals, a US based biotechnology firm, obtained US Food and Drug Administration (FDA) endorsement for CASGEVY (exagamglogene autotemcel, or exa cel), identified as a CRISPR Cas9 based gene editing cell therapy specifically for transfusion dependent ß thalassemia. This particular therapy utilizes autologous CD34+ stem and progenitor cells, modifies the erythroid specific BCL11A enhancer to increase fetal hemoglobin levels, and has shown enduring clinical enhancements, offering the prospect of attaining transfusion independence for numerous patients and substantially lessening or eradicating the necessity for routine blood transfusions.
Which Firms Are Competing In The Advanced Therapy Medicinal Products Market?
Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc
Access The Complete Advanced Therapy Medicinal Products Market Report:
What Is The Largest Regional Market In The Advanced Therapy Medicinal Products Market?
North America was the largest region in the advanced therapy medicinal products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Advanced Therapy Medicinal Products Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Market 2026, By The Business Research Company
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Herbal Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/herbal-medicine-global-market-report
Anti Inflammatory Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
